SCHEMBL805300

SCHEMBL805300

CC(C)C(=O)OCC(F)(F)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.41
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17545733 0.87 HTT (0.39) HTTALDH1A1POLBMAPT
SCHEMBL16547501 0.86 FGFR1 (0.38) HTT
SCHEMBL16525497 0.85 HTT (0.38) HTTALDH1A1POLBMAPT
SCHEMBL16525491 0.84 HTT (0.36) HTTALDH1A1POLBMAPT
SCHEMBL18031821 0.83 HTT (0.39) HTTALDH1A1POLBMAPT
SCHEMBL18175694 0.83 HTT (0.39) HTT
SCHEMBL13790831 0.82 HTT (0.35) HTTALDH1A1POLBMAPT
SCHEMBL21993898 0.82 HTT (0.41) HTTALDH1A1POLBMAPT
SCHEMBL805296 0.81 HTT (0.62) HTTALDH1A1POLBMAPT
SCHEMBL17545754 0.81 HTT (0.38) HTTALDH1A1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4318629-A1 PRIMER FOR POWER STORAGE DEVICE ELECTRODES, COMPOSITION FOR FORMING PRIMER LAYER, ELECTRODE FOR POWER STORAGE DEVICES, AND SECONDARY BATTERY AGC INC. (JP) 2024-02-07 EP disclosed
US-20230420686-A1 PRIMER FOR POWER STORAGE DEVICE ELECTRODE, COMPOSITION FOR FORMING PRIMER LAYER, ELECTRODE FOR POWER STORAGE DEVICE, AND SECONDARY BATTERY AGC Inc. (JP) 2023-12-28 US disclosed
US-20180006324-A1 ELECTROLYTE, BATTERY, BATTERY PACK, ELECTRONIC APPARATUS, ELECTRIC VEHICLE, POWER STORAGE APPARATUS, AND POWER SYSTEM TOHOKU MURATA MANUFACTURING CO., LTD. (JP) 2018-01-04 US disclosed
US-9760005-B2 Salt, acid generator, resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-09-12 US disclosed
US-20160062233-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-03-03 US disclosed
EP-2450406-B1 FLUORINE-CONTAINING COPOLYMER COMPOSITION AND METHOD FOR PRODUCING SAME ASAHI GLASS CO LTD (JP) 2015-10-14 EP disclosed
US-20140073719-A1 SYNTHESIS OF SUPERHYDROPHOBIC COPOLYMER USING CARBON DIOXIDE SOLVENT AND APPLICATION THEREOF KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2014-03-13 US disclosed
US-8331015-B2 Display medium and display device FUJI XEROX CO., LTD. (JP) 2012-12-11 US disclosed
EP-2450406-A1 FLUORINE-CONTAINING COPOLYMER COMPOSITION AND METHOD FOR PRODUCING SAME Asahi Glass Company, Limited (JP) 2012-05-09 EP disclosed
US-20120108723-A1 FLUOROCOPOLYMER COMPOSITION AND ITS PRODUCTION PROCESS ASAHI GLASS COMPANY, LIMITED (JP) 2012-05-03 US disclosed
US-20120069423-A1 DISPLAY MEDIUM AND DISPLAY DEVICE FUJI XEROX CO., LTD. (JP) 2012-03-22 US disclosed
US-7550458-B2 Tricycloundecane compounds useful as modulators of nuclear hormone receptor function BRISTOL-MYERS SQUIBB COMPANY (US) 2009-06-23 US disclosed
US-20070088029-A1 Tricycloundecane compounds useful as modulators of nuclear hormone receptor function BRISTOL-MYERS SQUIBB COMPANY 2007-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160062233-A1 SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN XDH, HAX1, MLX HTT 2843/4885ALDH1A1 2530/4885POLB 1000/4885
US-20070088029-A1 Tricycloundecane compounds useful as modulators of nuclear hormone receptor function VDR, ESRRB, NR5A1 HTT 3950/4885ALDH1A1 3634/4885POLB 2097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.